FDA.reportPublic FDA data

XIPERE 40 MG in 0.9 ML Injection

RxCUI
2585226
RxNorm name
XIPERE 40 MG in 0.9 ML Injection
Display name
XIPERE 40 MG in 0.9 ML Injection
Full name
XIPERE 40 MG in 0.9 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XipereTRIAMCINOLONE ACETONIDEBausch & Lomb Incorporatedea6ad429-967f-4f75-a33d-e06f849bee802025-10-08Warnings, Adverse reactionsExact identifier
rxcui: 2585226

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ea6ad429-967f-4f75-a33d-e06f849bee80XIPERE 40 MG in 0.9 ML Injection [PSN] · 0.9 ML triamcinolone acetonide 40 MG/ML Injection [Xipere] [SBD] · 0.9 ML Xipere 40 MG/ML Injection [SY] · Xipere 40 MG per 0.9 ML Injection [SY]47These highlights do not include all the information needed to use XIPERE ® safely and effectively. See full prescribing information for XIPERE ® . XIPERE ® (triamcinolone acetonide injectable suspension), for suprachoroidal use Initial U.S. Approval: 195720251008